🇺🇸 AMGN — Amgen Inc.

Healthcare Compra
← Volver

Precio actual

437,23 USD

Máx. histórico

447,03

10 días

Caída desde máximo

-2,19%

Rango 52 semanas

269,77 – 447,03

Variación hoy

-1,55%

Cierre anterior

444,12

Rango de hoy

435,01 – 441,66

Volumen hoy

1.615.172

Información
Nombre completo
Amgen Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
31.500
PER ⓘ
27,17 (puede no estar actualizado)
Dividend yield
2,27% (puede no estar actualizado)
Precio objetivo analistas
389,69 USD (puede no estar actualizado)
Primera cotización
17/06/1983
Precio actualizado
hace 2 días
Sobre la empresa

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including PROLIA, REPATHA, OTEZLA, ENBREL, EVENITY, XGEVA, TEPEZZA, BLINCYTO, NPLATE, TEZSPIRE, KYPROLIS, ARANESP, KRYSTEXXA AND VECTIBIX, MVASI, PAVBLU, UPLIZNA, IMDELLTRA/IMDYLLTRA, AMJEVITA/AMGEVITA, TAVNEOS, NEULASTA, LUMAKRAS/LUMYKRAS, RAVICTI, PARSABIV, AIMOVIG, WEZLANA/WEZENLA, AND PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; BEONE MEDICINES LTD. to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. The company was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Dividendos repartidos Total últimos 12 meses: 9,9400 USD · Yield: 2,27%
Fecha de pago Importe por participación
14/02/2019 1,4500 USD
15/11/2018 1,3200 USD
16/08/2018 1,3200 USD
16/05/2018 1,3200 USD
14/02/2018 1,3200 USD
16/11/2017 1,1500 USD
15/08/2017 1,1500 USD
15/05/2017 1,1500 USD
13/02/2017 1,1500 USD
14/11/2016 1,0000 USD
15/08/2016 1,0000 USD
13/05/2016 1,0000 USD
11/02/2016 1,0000 USD
12/11/2015 0,7900 USD
13/08/2015 0,7900 USD
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
25/08/2016 169,92 171,46 168,76 170,23 -0,36% 1,59% 2.623.800
24/08/2016 174,00 174,87 170,28 170,84 -2,04% 2,64% 3.055.000
23/08/2016 174,44 175,99 173,66 174,40 +0,03% 1,34% 2.375.700
22/08/2016 173,74 175,18 173,22 174,35 +0,42% 1,13% 2.603.700
19/08/2016 174,10 174,96 172,26 173,62 -0,65% 1,55% 2.696.400
18/08/2016 174,43 176,64 173,57 174,75 +0,25% 1,76% 3.422.400
17/08/2016 172,01 174,50 171,68 174,31 +1,25% 1,64% 2.580.900
16/08/2016 174,54 174,91 172,07 172,16 -1,39% 1,63% 2.622.800
15/08/2016 171,48 174,72 171,48 174,58 +0,90% 1,89% 2.784.300
12/08/2016 171,24 173,15 170,68 173,02 +0,34% 1,44% 1.863.200
11/08/2016 172,24 172,78 171,05 172,43 +0,70% 1,00% 2.142.800
10/08/2016 171,89 172,20 170,71 171,23 -0,49% 0,87% 2.476.600
09/08/2016 172,66 173,30 171,68 172,08 -0,15% 0,94% 2.094.200
08/08/2016 173,31 174,16 171,83 172,34 -0,76% 1,34% 2.706.500
05/08/2016 173,35 174,52 172,51 173,66 +0,57% 1,16% 2.228.300
04/08/2016 173,30 173,67 172,04 172,67 -0,44% 0,94% 2.122.200
03/08/2016 173,74 174,39 172,28 173,43 -0,41% 1,21% 3.911.800
02/08/2016 175,05 176,50 173,17 174,15 -0,01% 1,90% 6.589.000
01/08/2016 172,91 174,98 172,28 174,16 +1,24% 1,56% 3.571.900
29/07/2016 171,57 172,26 170,53 172,03 +0,44% 1,01% 3.121.600
28/07/2016 168,93 171,80 166,51 171,28 +0,35% 3,13% 5.192.500
27/07/2016 167,45 171,09 167,44 170,68 +1,80% 2,18% 4.200.200
26/07/2016 165,89 168,05 165,77 167,67 +0,67% 1,37% 2.883.600
25/07/2016 165,70 166,95 164,07 166,56 +0,54% 1,74% 2.704.900
22/07/2016 164,78 166,33 164,00 165,67 +0,90% 1,41% 2.500.400
21/07/2016 163,39 164,26 162,71 164,19 +0,58% 0,95% 1.971.800
20/07/2016 162,45 163,65 161,82 163,25 +0,47% 1,13% 2.161.400
19/07/2016 163,20 164,71 161,94 162,49 -0,27% 1,70% 2.249.500
18/07/2016 163,82 164,00 162,79 162,93 -0,21% 0,74% 1.815.600
15/07/2016 163,45 164,57 161,56 163,28 +0,33% 1,84% 3.179.700